Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo

V.A. Gault, J.C. Parker, Patrick Harriott, P.R. Flatt, F.P.M. O'Harte

Research output: Contribution to journalArticlepeer-review

90 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Food Science

Chemistry